Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant i » significant _ (Expand Search), significant co (Expand Search), significant 17 (Expand Search)
i decrease » _ decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
Showing 3,521 - 3,540 results of 21,342 for search '(( significant decrease decrease ) OR ( significant i decrease ))', query time: 0.57s Refine Results
  1. 3521
    Representative image data in Fig 5.

    Representative image data in Fig 5. by Naoto Arimura (416442)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 3522
    Pharmacokinetics and pharmacodynamics of compound 4f in mice.

    Pharmacokinetics and pharmacodynamics of compound 4f in mice. by Naoto Arimura (416442)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 3523
    The raw data for S2 Fig.

    The raw data for S2 Fig. by Hongjoo An (21703199)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 3524
    The raw data for Fig 5B.

    The raw data for Fig 5B. by Hongjoo An (21703199)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 3525
    Effects of compound 4f on cognitive function in mice with KA-induced neurodegeneration.

    Effects of compound 4f on cognitive function in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 3526
    The raw data for Fig 8A.

    The raw data for Fig 8A. by Hongjoo An (21703199)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 3527
    Effects of compound 4f on neuronal cell loss in mice with KA-induced neurodegeneration.

    Effects of compound 4f on neuronal cell loss in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 3528
    The raw data for Fig 6.

    The raw data for Fig 6. by Hongjoo An (21703199)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 3529
    The raw data for S4 Fig.

    The raw data for S4 Fig. by Hongjoo An (21703199)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 3530
    Comparison of altered gene expression across groups of saline/vehicle-, KA/vehicle-, and KA/compound 4f-treated mice.

    Comparison of altered gene expression across groups of saline/vehicle-, KA/vehicle-, and KA/compound 4f-treated mice. by Naoto Arimura (416442)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 3531
    Effects of compound 4f on the seizure-like response elicited by kainic acid (KA).

    Effects of compound 4f on the seizure-like response elicited by kainic acid (KA). by Naoto Arimura (416442)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 3532
    Recruitment flow diagram of the current study.

    Recruitment flow diagram of the current study. by Somayeh Momenyan (10111603)

    Published 2025
    “…Phase 1 EQ-VAS decreases were associated with female sex, lower somatic symptom, fewer comorbidities, lack of expectation for a fast recovery, higher ISS, higher injury pain, neck, spine/back or lower extremity injuries. …”
    Save to List
    Saved in:
  13. 3533
    Stratified <i>Giardia</i> infection prevalence rates in nonhuman mammalian hosts based on ecological and biological characteristics.

    Stratified <i>Giardia</i> infection prevalence rates in nonhuman mammalian hosts based on ecological and biological characteristics. by Kareem Hatam-Nahavandi (7384790)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 3534
    <i>hdc</i> silencing results in cellular stress in the hematopoietic niche.

    <i>hdc</i> silencing results in cellular stress in the hematopoietic niche. by Bayan Kharrat (19959505)

    Published 2024
    Save to List
    Saved in:
  15. 3535
    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  16. 3536
    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  17. 3537
    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  18. 3538
    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  19. 3539
    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  20. 3540
    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:

Search Tools: